Pediatric injury patterns by year of age

Elisabeth T Tracy1, Brian R Englum, Andrew S Barbas

  • 1Department of General Surgery, Children's Hospital Boston, Boston, MA, USA.

Insights

Understanding pediatric trauma patterns is key to reducing child injuries. Motor-vehicle collisions and falls are leading causes, with specific trends in penetrating trauma needing attention for targeted prevention.

Area of Science:

  • Pediatric Trauma Research
  • Injury Epidemiology
  • Public Health

Background:

  • Trauma is a leading cause of death and disability in children.
  • Understanding age-specific injury patterns can inform targeted prevention strategies.
  • National databases offer valuable insights into pediatric injury trends.

Purpose of the Study:

  • To identify pediatric injury patterns by year of age.
  • To analyze leading mechanisms of injury (MOI) across different pediatric age groups.
  • To inform targeted injury prevention efforts through data-driven insights.

Main Methods:

  • Utilized the National Trauma Database (NTDB) Research Data Set 7.0 for patients aged 0-18 years.
  • Included relevant ICD-9 external-cause-of-injury codes (e-codes).
  • Analyzed data using χ(2) analysis and ANOVA, with significance defined as p<0.05.

Main Results:

  • Identified 354,196 pediatric trauma patients.
  • Leading MOI: motor-vehicle collisions (MVC) for ages 10-18, falls for ages 0-9.
  • Higher rates of penetrating trauma observed in adolescents with public/no insurance; highest injury severity in infants and older adolescents.

Conclusions:

  • Motor-vehicle collisions and falls remain primary pediatric injury mechanisms.
  • Year-of-age analysis revealed significant trends, including unexpected rates of penetrating trauma.
  • Findings support the development of targeted injury prevention strategies for pediatric populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...